Xeljanz (Tofacitinib)

Description

Xeljanz is an oral medication that works by inhibiting Janus kinase (JAK) pathways involved in immune response. It is used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, helping to reduce inflammation and disease progression.